‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address
In Brief: NBCC Wins Grants To Train Breast Cancer Activists In Language, Concepts Of Science
Latest Statistics Show Decline In Deaths From Breast Cancer
“What Is Good For NCI Is Good For NIH,” Broder Says In Address
Proposed Deal Could Resolve Key Disputes At NSABP, Pitt
NIH Reconsiders Closing A Meeting Of Advisory Group
NIH Extramural Office Lists Initiatives For Reinvention
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
